Palomeras, S., Diaz-Lagares, A., Viñas, G., Setién, F., Ferreira, H. J., Oliveras Serrat, G., . . . Puig i Miquel, T. (2019). Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer.
Citación estilo ChicagoPalomeras, Sonia, et al. Epigenetic Silencing of TGFBI Confers Resistance to Trastuzumab in Human Breast Cancer. 2019.
Cita MLAPalomeras, Sonia, et al. Epigenetic Silencing of TGFBI Confers Resistance to Trastuzumab in Human Breast Cancer. 2019.
Precaución: Estas citas no son 100% exactas.